What is the current valuation of the US medicinal plant-extracts market as of 2024?

The market was valued at $2250.0 Million in 2024. Read More

What is the projected market valuation for the US medicinal plant-extracts market in 2035?

The market is projected to reach $4750.0 Million by 2035. Read More

What is the expected CAGR for the US medicinal plant-extracts market during the forecast period 2025 - 2035?

The expected CAGR is 7.03% during the forecast period 2025 - 2035. Read More

Which segments contributed to the valuation of the US medicinal plant-extracts market?

Key segments include Leaf ($1350.0 - $2850.0 Million) and Medicinal products ($1500.0 - $3000.0 Million). Read More

Who are the key players in the US medicinal plant-extracts market?

Key players include Herbalife, Amway, Nature's Way, and Gaia Herbs. Read More

What are the different forms of medicinal plant extracts available in the market?

Forms include Liquid ($900.0 - $1900.0 Million), Powder ($600.0 - $1200.0 Million), and Oil ($500.0 - $1000.0 Million). Read More

What types of products are included in the US medicinal plant-extracts market?

Types include Herbal extracts ($450.0 - $950.0 Million) and Essential Oils ($600.0 - $1300.0 Million). Read More

What applications are driving the demand for medicinal plant extracts?

Applications include Medicinal products ($1500.0 - $3000.0 Million) and Personal care ($450.0 - $950.0 Million). Read More

How does the market for leaf extracts compare to other parts of the plant?

Leaf extracts dominate with a valuation range of $1350.0 - $2850.0 Million, surpassing other parts. Read More

What is the potential for growth in the US medicinal plant-extracts market?

The market appears poised for growth, with a projected increase to $4750.0 Million by 2035. Read More

US Medicinal Plant Extracts Market

US Medicinal Plant Extracts Market Research Report By Type (Spices, Essential Oils, Phytochemicals, Herbal Extracts, others), By Part (Leaf, Seed, Shell, others), By Application (Medicinal Products, Personal Care, Others) and By Form (Powder, Oil, others) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

7.03%

2024 Market Size

$ 2,250 Million

2035 Market Size

$ 4,750 Million

Healthcare ● Updated August 2026 Report ID: MRFR/HC/14010-HCR | Pages: 100 | Author: Satyendra Maurya, Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Parts (USD Million)
  1. 4.1.1 Seed
  2. 4.1.2 Shell
  3. 4.1.3 Leaf
  4. 4.1.4 Others
2. 4.2 Pharmaceutical, BY Applications (USD Million)
  1. 4.2.1 Personal care
  2. 4.2.2 Medicinal products
  3. 4.2.3 Others
3. 4.3 Pharmaceutical, BY Form (USD Million)
  1. 4.3.1 Liquid
  2. 4.3.2 Powder
  3. 4.3.3 Oil
  4. 4.3.4 Others
4. 4.4 Pharmaceutical, BY Types (USD Million)
  1. 4.4.1 Herbal extracts
  2. 4.4.2 Essential Oils
  3. 4.4.3 Spices
  4. 4.4.4 Phytochemicals
  5. 4.4.5 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Herbalife (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Amway (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Nature's Way (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Gaia Herbs (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Schwabe Pharmaceuticals (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Indena S.p.A. (IT)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Martin Bauer Group (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Dabur India Ltd. (IN)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Himalaya Wellness (IN)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
  10. 5.2.10 Nutraceutical Corporation (US)
    1. 5.2.10.1 Financial Overview
    2. 5.2.10.2 Products Offered
    3. 5.2.10.3 Key Developments
    4. 5.2.10.4 SWOT Analysis
    5. 5.2.10.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY PARTS
3. 6.3 US MARKET ANALYSIS BY APPLICATIONS
4. 6.4 US MARKET ANALYSIS BY FORM
5. 6.5 US MARKET ANALYSIS BY TYPES
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY PARTS, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY PARTS, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY APPLICATIONS, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY APPLICATIONS, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY FORM, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY FORM, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY TYPES, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY TYPES, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PARTS, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATIONS, 2025-2035 (USD Million)
  3. 7.2.3 BY FORM, 2025-2035 (USD Million)
  4. 7.2.4 BY TYPES, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Medicinal Plant Extracts Market Segmentation

US Medicinal Plant Extracts Market By Parts (USD Million, 2025-2035)

Seed
Shell
Leaf
Others

US Medicinal Plant Extracts Market By Applications (USD Million, 2025-2035)

Personal care
Medicinal products
Others

US Medicinal Plant Extracts Market By Form (USD Million, 2025-2035)

Liquid
Powder
Oil
Others

US Medicinal Plant Extracts Market By Types (USD Million, 2025-2035)

Herbal extracts
Essential Oils
Spices
Phytochemicals
Others

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”